Joseph Pantginis analyst HC WAINWRIGHT

Currently, out of the existing stock ratings of Joseph Pantginis - 268 which are a Buy (97.45%), 7 which are a Hold (2.55%)

Joseph Pantginis

Work Performance Price Targets & Ratings Chart

Analyst Joseph Pantginis works at HC WAINWRIGHT and is covering the Healthcare sector with 549 price targets and ratings displayed on 48 stocks. Previously, Joseph Pantginis worked at ROTH.

Joseph Pantginis's average stock forecast success ratio is 17.88% with an average time for price targets to be met of 125.41 days.

Most recent stock forecast was given on PDSB, at 20-Sep-2023.

Wall Street Analyst Joseph Pantginis

Analyst best performing recommendations are on PROG.
The best stock recommendation documented was for BMEA at 1/13/2023. The price target of $37 was fulfilled within 143 days with a profit of $29.56 (397.31%) receiving and performance score of 27.78.

Average potential price target upside

ADRO ATNM Actinium Pharmaceuticals CAPR Capricor Therapeutics CLBS Caladrius Biosciences LCTX PTN Palatin Technologies REGN Regeneron Pharmaceuticals SSKN STRATA Skin Sciences XBIO Xenetic Biosciences AGTC Applied Genetic Technologies CYTK Cytokinetics LGND Ligand Pharmaceuticals VSTM Verastem APTO Aptose Biosciences CLDX Celldex Therapeutics DBTX IOVA Iovance Biotherapeutics KRYS Krystal Biotech KURA Kura Oncology LIFE aTyr Pharma PHGE PROG RIGL Rigel Pharmaceuticals BCDA BYSI BeyondSpring KDNY SIOX VYNE XOMA XOMA CLNN CMPX BMEA CKPT IMV ARAV Aravive ARMP ATXS BCEL Atreca BNOX BPTS ESPR Esperion Therapeutics GNTA MDGL Madrigal Pharmaceuticals NVCT PDSB STTK TNYA TPST

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score



$8.45 (73.16%)


6 years 10 months 27 days ago

5/5 (100%)

$-59.3 (-55.17%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Joseph Pantginis is most bullish on?

Potential upside of $82.94 has been obtained for LGND (LIGAND PHARMACEUTICALS)

Which stock is Joseph Pantginis is most reserved on?

Potential downside of -$0 has been obtained for DBTX

What Year was the first public recommendation made by Joseph Pantginis?

On 2010

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart